Search - tctmd.com

Displaying 121 - 140 of 213

Sort: Relevancy | Date

News Daily News

Women More Often Than Men Report Lingering Angina After PCI, Raising More Questions

L.A. McKeown

March 06, 2016

News Daily News

生物可吸收支架导致装置血栓风险增加，但一些人士表示风险可得到抑制

Michael O'Riordan

February 23, 2016

News Daily News

Mayor Riesgo de Trombsosis del Dispositivo con Andamiajes Bioabsorbibles Aunque Algunos Riesgos Pueden Mitigarse

Michael O'Riordan

February 23, 2016

News Daily News

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

Michael O'Riordan

February 23, 2016

Presentation

Bioresorbable Coronary Scaffold Thrombosis

Presenter: S. Puricel

February 22, 2016

Presentation JIM 2016

BRS complication case examples: thrombosis, intraluminal scaffold dismantling, neoatherosclerosis, restenosis and more

Presenter: Yoshinobu Onuma

February 10, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2016

Shelley Wood

February 01, 2016

News Features

Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold

Michael O'Riordan

January 06, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Daily News

Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves

Caitlin E. Cox

November 26, 2015

News Features

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Todd Neale

November 08, 2015

Presentation TCT 2015

Imaging Insights Into BRS Failure Modes (Thrombosis and Restenosis)

Presenter: Detlef G. Mathey, Nicolas M. Van Mieghem, Yoshinobu Onuma

October 14, 2015

Presentation TCT 2015

Incidence and Predictors of BRS Scaffold Thrombosis

Presenter: Detlef G. Mathey, Nicolas M. Van Mieghem, Luis Ortega Paz, MD

October 14, 2015

News Industry News

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

October 12, 2015

News Conference News TCT 2015

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

October 12, 2015

News Conference News TCT 2015

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Yael L. Maxwell

October 12, 2015

News Industry News

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

October 12, 2015

News Conference News TCT 2015

ABSORB II: Absorb BVS, Xience Yield Similar Outcomes at 2 Years

October 12, 2015

News Conference News TCT 2015

Absorb BVS Matches Xience V in Chinese Patients

Todd Neale

October 12, 2015

News Daily News

Good Outcomes of Novel Bioresorbable-Polymer SES Persist at 2 Years

Yael L. Maxwell

October 02, 2015

Advertisement

Women More Often Than Men Report Lingering Angina After PCI, Raising More Questions

生物可吸收支架导致装置血栓风险增加，但一些人士表示风险可得到抑制

Mayor Riesgo de Trombsosis del Dispositivo con Andamiajes Bioabsorbibles Aunque Algunos Riesgos Pueden Mitigarse

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

Bioresorbable Coronary Scaffold Thrombosis

BRS complication case examples: thrombosis, intraluminal scaffold dismantling, neoatherosclerosis, restenosis and more

TCTMD’s Top 10 Most Popular Stories for January 2016

Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Imaging Insights Into BRS Failure Modes (Thrombosis and Restenosis)

Incidence and Predictors of BRS Scaffold Thrombosis

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

ABSORB II: Absorb BVS, Xience Yield Similar Outcomes at 2 Years

Absorb BVS Matches Xience V in Chinese Patients

Good Outcomes of Novel Bioresorbable-Polymer SES Persist at 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content